Benzimidazole carboxamides as RAF kinase inhibitors

Details for Australian Patent Application No. 2004255402 (hide)

Owner Merck Patent GmbH

Inventors Zenke, Frank; Grell, Matthias; Wiesner, Matthias; Amendt, Christiane; Buchstaller, Hans-Peter; Sirrenberg, Christian

Agent Davies Collison Cave

Pub. Number AU-B-2004255402

PCT Pub. Number WO2005/004863

Priority 03015583.2 11.07.03 EP

Filing date 11 June 2004

Wipo publication date 20 January 2005

Acceptance publication date 11 February 2010

International Classifications

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

2 March 2006 PCT application entered the National Phase

  PCT publication WO2005/004863 Priority application(s): WO2005/004863

11 February 2010 Application Accepted

  Published as AU-B-2004255402

10 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004255403-Benzimidazole derivatives as RAF kinase inhibitors

2004255393-Adjuvant combinations of liposomes and mycobacterial lipids for immunization compositions and vaccines